WO1994012192A1
(en)
|
1992-12-01 |
1994-06-09 |
Commonwealth Scientific And Industrial Research Organisation |
Antiviral agents
|
EP1302468B1
(en)
|
1992-12-29 |
2008-12-17 |
Abbott Laboratories |
Processes and intermediates for manufacturing retroviral protease inhibiting compounds
|
IL110752A
(en)
|
1993-09-13 |
2000-07-26 |
Abbott Lab |
Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor
|
US5559158A
(en)
|
1993-10-01 |
1996-09-24 |
Abbott Laboratories |
Pharmaceutical composition
|
IL111991A
(en)
|
1994-01-28 |
2000-07-26 |
Abbott Lab |
Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
|
US6037157A
(en)
|
1995-06-29 |
2000-03-14 |
Abbott Laboratories |
Method for improving pharmacokinetics
|
US6054472A
(en)
|
1996-04-23 |
2000-04-25 |
Vertex Pharmaceuticals, Incorporated |
Inhibitors of IMPDH enzyme
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
NZ332405A
(en)
|
1996-04-23 |
2000-06-23 |
Vertex Pharma |
oxazolyl, thiazolyl or phenyl urea derivatives as inhibitors of inosine monophosphate dehydrogenase enzyme
|
EP0907659A1
(en)
|
1996-05-10 |
1999-04-14 |
Schering Corporation |
Synthetic inhibitors of hepatitis c virus ns3 protease
|
SK286105B6
(en)
|
1996-10-18 |
2008-03-05 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease, pharmaceutical composition and their use
|
GB9623908D0
(en)
|
1996-11-18 |
1997-01-08 |
Hoffmann La Roche |
Amino acid derivatives
|
WO1998040381A1
(en)
|
1997-03-14 |
1998-09-17 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of impdh enzyme
|
GB9707659D0
(en)
|
1997-04-16 |
1997-06-04 |
Peptide Therapeutics Ltd |
Hepatitis C NS3 Protease inhibitors
|
IL134232A0
(en)
|
1997-08-11 |
2001-04-30 |
Boehringer Ingelheim Ca Ltd |
Hepatitis c inhibitor peptides
|
EP1012180B1
(en)
|
1997-08-11 |
2004-12-01 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis c inhibitor peptide analogues
|
IT1299134B1
(en)
|
1998-02-02 |
2000-02-29 |
Angeletti P Ist Richerche Bio |
PROCEDURE FOR THE PRODUCTION OF PEPTIDES WITH PROTEAS INHIBITING THE NS3 PROTEASIS OF THE HCV VIRUS, PEPTIDES SO OBTAINABLE AND PEPTIDES
|
EP1066247B1
(en)
|
1998-03-31 |
2006-11-22 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
|
GB9812523D0
(en)
|
1998-06-10 |
1998-08-05 |
Angeletti P Ist Richerche Bio |
Peptide inhibitors of hepatitis c virus ns3 protease
|
US6323180B1
(en)
|
1998-08-10 |
2001-11-27 |
Boehringer Ingelheim (Canada) Ltd |
Hepatitis C inhibitor tri-peptides
|
DE19836514A1
(en)
|
1998-08-12 |
2000-02-17 |
Univ Stuttgart |
Modification of engineering polymers with N-basic groups and ion exchange groups in the side chain gives membranes of good thermal and mechanical stability useful for fuel cells, diffusion dialysis, electrodialysis, and reverse osmosis
|
GB9825946D0
(en)
|
1998-11-26 |
1999-01-20 |
Angeletti P Ist Richerche Bio |
Pharmaceutical compounds for the inhibition of hepatitis C virus NS3 protease
|
NZ514540A
(en)
|
1999-03-19 |
2003-11-28 |
Vertex Pharma |
Phenyl derivative useful as inhibitors of IMPDH enzyme
|
UA74546C2
(en)
|
1999-04-06 |
2006-01-16 |
Boehringer Ingelheim Ca Ltd |
Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition
|
US6608027B1
(en)
|
1999-04-06 |
2003-08-19 |
Boehringer Ingelheim (Canada) Ltd |
Macrocyclic peptides active against the hepatitis C virus
|
CA2376961A1
(en)
|
1999-07-26 |
2001-02-01 |
Bristol-Myers Squibb Pharma Company |
Lactam inhibitors of hepatitis c virus ns3 protease
|
US7122627B2
(en)
|
1999-07-26 |
2006-10-17 |
Bristol-Myers Squibb Company |
Lactam inhibitors of Hepatitis C virus NS3 protease
|
RU2223761C2
(en)
|
1999-12-27 |
2004-02-20 |
Джапан Тобакко Инк. |
Ring-condensed compounds and their using as medicinal agents
|
US6770666B2
(en)
|
1999-12-27 |
2004-08-03 |
Japan Tobacco Inc. |
Fused-ring compounds and use thereof as drugs
|
CA2396504A1
(en)
|
2000-02-29 |
2001-09-07 |
Dupont Pharmaceuticals Company |
Inhibitors of hepatitis c virus ns3 protease
|
EP1268519B1
(en)
|
2000-04-03 |
2005-06-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
|
CA2405521C
(en)
|
2000-04-05 |
2010-06-29 |
Schering Corporation |
Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties
|
AU2001253206A1
(en)
|
2000-04-05 |
2001-10-23 |
Tularik, Inc. |
Ns5b hcv polymerase inhibitors
|
BR0110104A
(en)
|
2000-04-19 |
2003-01-07 |
Schering Corp |
Macroscopic hepatitis C virus ns-3 serine rotease inhibitors comprising portions of p2 alkyl and aryl alanine
|
US6448281B1
(en)
|
2000-07-06 |
2002-09-10 |
Boehringer Ingelheim (Canada) Ltd. |
Viral polymerase inhibitors
|
GB0017676D0
(en)
|
2000-07-19 |
2000-09-06 |
Angeletti P Ist Richerche Bio |
Inhibitors of viral polymerase
|
JP4298289B2
(en)
|
2000-07-21 |
2009-07-15 |
シェーリング コーポレイション |
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
|
PL365695A1
(en)
|
2000-07-21 |
2005-01-10 |
|
Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
|
AR029851A1
(en)
|
2000-07-21 |
2003-07-16 |
Dendreon Corp |
NEW PEPTIDES AS INHIBITORS OF NS3-SERINA PROTEASA DEL VIRUS DE HEPATITIS C
|
AR034127A1
(en)
|
2000-07-21 |
2004-02-04 |
Schering Corp |
IMIDAZOLIDINONES AS INHIBITORS OF NS3-SERINA PROTEASA OF THE HEPATITIS C VIRUS, PHARMACEUTICAL COMPOSITION, A METHOD FOR THEIR PREPARATION, AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
|
SV2003000617A
(en)
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
INHIBITORS OF PROTEASA PEPTIDOMIMETICA REF. X-14912M
|
US6846806B2
(en)
|
2000-10-23 |
2005-01-25 |
Bristol-Myers Squibb Company |
Peptide inhibitors of Hepatitis C virus NS3 protein
|
JP3889708B2
(en)
|
2000-11-20 |
2007-03-07 |
ブリストル−マイヤーズ スクイブ カンパニー |
Hepatitis C tripeptide inhibitor
|
US6727366B2
(en)
|
2000-12-13 |
2004-04-27 |
Bristol-Myers Squibb Pharma Company |
Imidazolidinones and their related derivatives as hepatitis C virus NS3 protease inhibitors
|
AU2002230763A1
(en)
|
2000-12-13 |
2008-01-03 |
Bristol-Myers Squibb Pharma Company |
Inhibitors of hepatitis c virus ns3 protease
|
GB0107924D0
(en)
|
2001-03-29 |
2001-05-23 |
Angeletti P Ist Richerche Bio |
Inhibitor of hepatitis C virus NS3 protease
|
KR100798579B1
(en)
|
2001-03-31 |
2008-01-28 |
동화약품공업주식회사 |
Novel methoxy-1,3,5-triazine derivatives and the pharmaceutical compositions containing said derivatives
|
MXPA03011452A
(en)
|
2001-06-11 |
2005-03-07 |
Virochem Pharma Inc |
Thiophene derivatives as antiviral agents for flavivirus infection.
|
AR035543A1
(en)
|
2001-06-26 |
2004-06-16 |
Japan Tobacco Inc |
THERAPEUTIC AGENT FOR HEPATITIS C THAT INCLUDES A CONDENSED RING COMPOUND, CONDENSED RING COMPOUND, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS, BENZIMIDAZOL, THIAZOL AND BIFENYL COMPOUNDS USED AS INTERMEDIARY COMPARTMENTS OF COMPARTMENTS
|
KR100713137B1
(en)
|
2001-06-28 |
2007-05-02 |
동화약품공업주식회사 |
Novel 2,4-difluorobenzamide derivatives
|
IL159087A0
(en)
|
2001-07-11 |
2004-05-12 |
Vertex Pharma |
Bridged bicyclic compounds and pharmaceutical compositions containing the same
|
JP4558314B2
(en)
|
2001-07-20 |
2010-10-06 |
ベーリンガー インゲルハイム (カナダ) リミテッド |
Viral polymerase inhibitor
|
EP2335700A1
(en)
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
US20030134853A1
(en)
|
2001-09-26 |
2003-07-17 |
Priestley Eldon Scott |
Compounds useful for treating hepatitis C virus
|
JP2005511573A
(en)
|
2001-11-02 |
2005-04-28 |
グラクソ グループ リミテッド |
4- (5-membered) -heteroarylacylpyrrolidine derivatives as HCV inhibitors
|
EP1440068A1
(en)
|
2001-11-02 |
2004-07-28 |
Glaxo Group Limited |
Acyl dihydro pyrrole derivatives as hcv inhibitors
|
DE60221627D1
(en)
|
2001-12-21 |
2007-09-20 |
Virochem Pharma Inc |
Thiazole derivatives and their use for the treatment or prevention of infections by flaviviruses
|
GB0201179D0
(en)
|
2002-01-18 |
2002-03-06 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
WO2003082848A1
(en)
|
2002-04-01 |
2003-10-09 |
Pfizer Inc. |
Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase
|
KR100516434B1
(en)
|
2002-04-04 |
2005-09-22 |
(주) 비엔씨바이오팜 |
6-(4-substituted-anilino)pyrimidine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same
|
TW200400818A
(en)
|
2002-05-21 |
2004-01-16 |
Wyeth Corp |
Method for the use of pyranoindole derivatives to treat infection with hepatitis C virus
|
TW200400963A
(en)
|
2002-05-21 |
2004-01-16 |
Wyeth Corp |
R-enantiomers of pyranoindole derivatives and the use thereof for the treatment of hepatitis C virus infection or disease
|
US7449488B2
(en)
|
2002-06-04 |
2008-11-11 |
Schering Corporation |
Pyrazolopyrimidines as protein kinase inhibitors
|
CN1671710A
(en)
|
2002-06-04 |
2005-09-21 |
新创世纪药品公司 |
Pyrazolo[1,5a]pyrimidine compounds as antiviral agents
|
US20040142993A1
(en)
|
2002-07-01 |
2004-07-22 |
Carlo Battistini |
Inhibitors of HCV NS5B polymerase
|
BR0305426A
(en)
|
2002-07-01 |
2004-08-24 |
Upjohn Co |
Hsv ns5b polymerase inhibitor compounds as well as pharmaceutical composition comprising the same
|
GB0216985D0
(en)
|
2002-07-22 |
2002-08-28 |
Glaxo Group Ltd |
Compounds
|
US7183302B2
(en)
|
2002-08-12 |
2007-02-27 |
Bristol-Myers Squibb Company |
Iminothiazolidinones as inhibitors of HCV replication
|
US7408078B2
(en)
|
2002-10-08 |
2008-08-05 |
Wyeth |
Anthranilic acid derivatives useful in treating infection with hepatitis C virus
|
KR100453946B1
(en)
|
2002-10-11 |
2004-10-20 |
(주) 비엔씨바이오팜 |
6-methylpyridine derivative, method for preparing thereof and antiviral pharmaceutical composition comprising the same
|
WO2004037818A1
(en)
|
2002-10-24 |
2004-05-06 |
Glaxo Group Limited |
1-acyl-pyrrolidine derivatives for the treatment of viral infections
|
US7902203B2
(en)
|
2002-11-01 |
2011-03-08 |
Abbott Laboratories, Inc. |
Anti-infective agents
|
PL376823A1
(en)
|
2002-11-01 |
2006-01-09 |
Abbott Laboratories |
Anti-infective agents
|
UA79834C2
(en)
|
2002-11-01 |
2007-07-25 |
Viropharma Inc |
Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
|
US20040162285A1
(en)
|
2002-11-01 |
2004-08-19 |
Pratt John K. |
Anti-infective agents
|
US20040097492A1
(en)
|
2002-11-01 |
2004-05-20 |
Pratt John K |
Anti-infective agents
|
ATE466856T1
(en)
|
2002-12-10 |
2010-05-15 |
Virochem Pharma Inc |
COMPOUNDS AND METHODS FOR TREATING OR PREVENTING FLAVIVIRUS INFECTIONS
|
AU2003291886A1
(en)
|
2002-12-10 |
2004-06-30 |
Virochem Pharma Inc. |
Thiophenederivatives for the treatment of flavivirus infections
|
US7223785B2
(en)
|
2003-01-22 |
2007-05-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
US7098231B2
(en)
|
2003-01-22 |
2006-08-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
JP2007524576A
(en)
|
2003-02-07 |
2007-08-30 |
エナンタ ファーマシューティカルズ インコーポレイテッド |
Macrocyclic hepatitis C serine protease inhibitor
|
JP2006517960A
(en)
|
2003-02-18 |
2006-08-03 |
ファイザー インコーポレイテッド |
Inhibitors of hepatitis C virus, compositions using the same and methods of treatment
|
US7148226B2
(en)
|
2003-02-21 |
2006-12-12 |
Agouron Pharmaceuticals, Inc. |
Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
|
GB0304494D0
(en)
|
2003-02-27 |
2003-04-02 |
Glaxo Group Ltd |
Compounds
|
US7956079B2
(en)
|
2003-03-10 |
2011-06-07 |
Mitsubishi Corporation |
Antihepatitis C virus agent and anti-HIV agent
|
GB0307891D0
(en)
|
2003-04-04 |
2003-05-14 |
Angeletti P Ist Richerche Bio |
Chemical compounds,compositions and uses
|
KR100502395B1
(en)
|
2003-06-04 |
2005-07-19 |
(주) 비엔씨바이오팜 |
4-[4-(4-Morpholino)anilino]pyrimidine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same
|
KR100502394B1
(en)
|
2003-06-04 |
2005-07-19 |
(주) 비엔씨바이오팜 |
2-[2-(4-Morpholino)ethylamino]pyridine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same
|
WO2005014543A1
(en)
|
2003-08-06 |
2005-02-17 |
Japan Tobacco Inc. |
Condensed ring compound and use thereof as hcv polymerase inhibitor
|
WO2005016932A1
(en)
|
2003-08-14 |
2005-02-24 |
Wyeth |
Pyranobenzothiophene derivatives to treat infection with hepatitis c virus
|
WO2005019191A2
(en)
|
2003-08-25 |
2005-03-03 |
Abbott Laboratories |
1, 1-dioxido-4h-1,2,4-benzothiadiazine derivate und verwandte verbindungen als inhibitoren der hcv polymerase zur behandlung von hepatitis c
|
US7378414B2
(en)
|
2003-08-25 |
2008-05-27 |
Abbott Laboratories |
Anti-infective agents
|
US7112601B2
(en)
|
2003-09-11 |
2006-09-26 |
Bristol-Myers Squibb Company |
Cycloalkyl heterocycles for treating hepatitis C virus
|
US7365092B2
(en)
|
2003-10-10 |
2008-04-29 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
|
GB0323845D0
(en)
|
2003-10-10 |
2003-11-12 |
Angeletti P Ist Richerche Bio |
Chemical compounds,compositions and uses
|
US7026339B2
(en)
|
2003-11-07 |
2006-04-11 |
Fan Yang |
Inhibitors of HCV NS5B polymerase
|
EP1688420A4
(en)
|
2003-11-19 |
2008-10-22 |
Japan Tobacco Inc |
5-5-membered fused heterocyclic compound and use thereof as hcv polymerase inhibitor
|
WO2005079799A1
(en)
|
2004-02-13 |
2005-09-01 |
Glaxo Group Limited |
4-acyl-piperazines as anti-viral agents
|
SG150511A1
(en)
|
2004-02-20 |
2009-03-30 |
Boehringer Ingelheim Int |
Viral polymerase inhibitors
|
RS50815B
(en)
|
2004-02-24 |
2010-08-31 |
Japan Tobacco Inc. |
Fused heterotetracyclic compunds and use thereof as hcv polymerase inhibitor
|
US20070167507A1
(en)
|
2004-03-26 |
2007-07-19 |
Glaxo Group Limited |
4-Carbox pyrazole derivatives useful as anti-viral agents
|
GB0408995D0
(en)
|
2004-04-22 |
2004-05-26 |
Glaxo Group Ltd |
Compounds
|
WO2005112640A2
(en)
|
2004-05-13 |
2005-12-01 |
Viropharma Incorporated |
Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
|
GB0413087D0
(en)
|
2004-06-11 |
2004-07-14 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
KR20070083484A
(en)
|
2004-07-14 |
2007-08-24 |
피티씨 테라퓨틱스, 인크. |
Methods for treating hepatitis c
|
UY29017A1
(en)
|
2004-07-16 |
2006-02-24 |
Boehringer Ingelheim Int |
VIRAL POLYMERASE INHIBITORS
|
GB0416396D0
(en)
|
2004-07-22 |
2004-08-25 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
EP1781289A1
(en)
|
2004-07-22 |
2007-05-09 |
PTC Therapeutics, Inc. |
Thienopyridines for treating hepatitis c
|
KR100638709B1
(en)
|
2004-07-28 |
2006-10-25 |
(주) 비엔씨바이오팜 |
N?Substituted?sulfamoylbenzoic acid derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same
|
US7153848B2
(en)
|
2004-08-09 |
2006-12-26 |
Bristol-Myers Squibb Company |
Inhibitors of HCV replication
|
CN101006092B
(en)
|
2004-08-18 |
2013-04-17 |
辉瑞有限公司 |
Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatment agent using the same
|
KR100847181B1
(en)
|
2004-08-23 |
2008-07-17 |
에프. 호프만-라 로슈 아게 |
Heterocyclic antiviral compounds
|
GB0419850D0
(en)
|
2004-09-07 |
2004-10-13 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
CN101035528A
(en)
|
2004-09-23 |
2007-09-12 |
惠氏公司 |
Carbazole and cyclopentaindole derivatives to treat infection with hepatitis C virus
|
GB0423672D0
(en)
|
2004-10-25 |
2004-11-24 |
Glaxo Group Ltd |
Compounds
|
GB0423673D0
(en)
|
2004-10-25 |
2004-11-24 |
Glaxo Group Ltd |
Compounds
|
AU2005298403A1
(en)
|
2004-10-26 |
2006-05-04 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Tetracyclic indole derivatives as antiviral agents
|
EP1814861A1
(en)
|
2004-10-29 |
2007-08-08 |
Schering Corporation |
Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents
|
US7659263B2
(en)
|
2004-11-12 |
2010-02-09 |
Japan Tobacco Inc. |
Thienopyrrole compound and use thereof as HCV polymerase inhibitor
|
WO2006065590A2
(en)
|
2004-12-16 |
2006-06-22 |
Xtl Biopharmaceuticals Inc. |
Pyridine and pyrimidine antiviral compositions
|
JP2008526687A
(en)
|
2004-12-17 |
2008-07-24 |
アナディス ファーマシューティカルズ インク |
Pyridazinone compounds
|
US8329703B2
(en)
|
2005-02-15 |
2012-12-11 |
Xtl Biopharmaceuticals Ltd. |
Pyrazole compounds
|
US20060217390A1
(en)
|
2005-02-24 |
2006-09-28 |
Esmir Gunic |
Cycloalkl, aryl and heteroaryl amino isothiazoles for the treatment of Hepatitis C virus
|
WO2006093801A1
(en)
|
2005-02-25 |
2006-09-08 |
Abbott Laboratories |
Thiadiazine derivatives useful as anti-infective agents
|
GB0505735D0
(en)
|
2005-03-21 |
2005-04-27 |
Glaxo Group Ltd |
Compounds
|
US20060223834A1
(en)
|
2005-04-04 |
2006-10-05 |
Vasu Nair |
Diketo acids on nucleobase scaffolds as inhibitors of Flaviviridae
|
EP1879885A1
(en)
|
2005-05-04 |
2008-01-23 |
F. Hoffmann-Roche AG |
Heterocyclic antiviral compounds
|
GB0509326D0
(en)
|
2005-05-09 |
2005-06-15 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
EA016071B1
(en)
|
2005-05-13 |
2012-01-30 |
Вирокем Фарма Инк. |
Compounds and methods for the treatment or prevention of flavivirus infections
|
US7994360B2
(en)
|
2005-05-16 |
2011-08-09 |
Xtl Biopharmaceuticals Ltd. |
Benzofuran compounds
|
WO2007002639A2
(en)
|
2005-06-24 |
2007-01-04 |
Migenix Inc. |
Non-nucleoside anti-hepacivirus agents and uses thereof
|
KR100700676B1
(en)
|
2005-06-24 |
2007-03-28 |
(주) 비엔씨바이오팜 |
6-4-Substituted-anilinopyrimidine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same
|
US20060293320A1
(en)
|
2005-06-24 |
2006-12-28 |
Genelabs Technologies, Inc. |
Heteroaryl derivatives for treating viruses
|
US20070032522A1
(en)
|
2005-07-01 |
2007-02-08 |
Kumar Dange V |
Antiviral agents
|
US20070032488A1
(en)
|
2005-08-05 |
2007-02-08 |
Genelabs Technologies, Inc. |
6-Membered aryl and heteroaryl derivatives for treating viruses
|
EP1915378A4
(en)
|
2005-08-12 |
2009-07-22 |
Boehringer Ingelheim Int |
Viral polymerase inhibitors
|
CN102336758A
(en)
|
2005-08-24 |
2012-02-01 |
辉瑞有限公司 |
Compound and combination as HCV polymerase inhibitors
|
AR055395A1
(en)
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
INHIBITING COMPOUNDS OF THE ACTIVITY OF SERINA PROTEASA NS3-NS4A OF HEPATITIS C VIRUS
|
WO2007028789A1
(en)
|
2005-09-07 |
2007-03-15 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa |
Quinazoline derivatives as antiviral agents
|
CA2622592A1
(en)
|
2005-09-19 |
2007-03-29 |
Arrow Therapeutics Limited |
Benzodiazepine derivatives for treating hepatitis c infection
|
GB0519485D0
(en)
|
2005-09-23 |
2005-11-02 |
Glaxo Group Ltd |
Compounds
|
AU2006299426B2
(en)
|
2005-09-30 |
2012-07-26 |
Scynexis, Inc. |
Methods and pharmaceutical compositions for the treatment and prevention of hepatitis C infection
|
JP2009520735A
(en)
|
2005-12-22 |
2009-05-28 |
スミスクライン・ビーチャム・コーポレイション |
Antiviral 2-carboxy-thiophene compound
|
WO2007082554A1
(en)
|
2006-01-23 |
2007-07-26 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Modulators of hcv replication
|
GB0602046D0
(en)
|
2006-02-01 |
2006-03-15 |
Smithkline Beecham Corp |
Compounds
|
WO2007092558A2
(en)
|
2006-02-08 |
2007-08-16 |
Wyeth |
Sulfonamide derivatives to treat infection with hepatitis c virus
|
US7456166B2
(en)
|
2006-05-17 |
2008-11-25 |
Bristol-Myers Squibb Company |
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
|
US7521441B2
(en)
|
2006-05-22 |
2009-04-21 |
Bristol-Myers Squibb Company |
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
|
JP5205370B2
(en)
|
2006-05-25 |
2013-06-05 |
ブリストル−マイヤーズ スクイブ カンパニー |
Cyclopropyl condensed indolobenzazepine HCVNS5B inhibitor
|
US7521442B2
(en)
|
2006-05-25 |
2009-04-21 |
Bristol-Myers Squibb Company |
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
|
US7452876B2
(en)
|
2006-06-08 |
2008-11-18 |
Bristol-Myers Squibb Company |
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
|
WO2007147794A1
(en)
|
2006-06-19 |
2007-12-27 |
Smithkline Beecham Corporation |
Furan derivatives and their use as antiviral agents
|
JP5306194B2
(en)
|
2006-06-22 |
2013-10-02 |
アナディス ファーマシューティカルズ インク |
Pyro [1,2-b] pyridazinone compounds
|
EP2044083A1
(en)
|
2006-07-14 |
2009-04-08 |
Genelabs Technologies, Inc. |
Antiviral agents
|
WO2008011337A1
(en)
|
2006-07-19 |
2008-01-24 |
Abbott Laboratories |
Hcv inhibitors
|
US9259426B2
(en)
|
2006-07-20 |
2016-02-16 |
Gilead Sciences, Inc. |
4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
|
AR062827A1
(en)
|
2006-07-20 |
2008-12-10 |
Genelabs Tech Inc |
POLYCLICAL VIRAL INHIBITORS, A PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND THEIR USE IN THE PREPARATION OF MEDICINES FOR THE TREATMENT OF A VIRAL INFECTION MEDIATED BY THE VIRUS OF HEPATITIS C
|
US8329159B2
(en)
|
2006-08-11 |
2012-12-11 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7659270B2
(en)
|
2006-08-11 |
2010-02-09 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
KR20090042973A
(en)
|
2006-08-17 |
2009-05-04 |
베링거 인겔하임 인터내셔날 게엠베하 |
Viral polymerase inhibitors
|